Grants and Contributions:

Title:
Clinical strains of P. aeruginosa from cystic fibrosis patients as targets for therapy
Agreement Number:
955911
Agreement Value:
$179,850.00
Agreement Date:
Aug 18, 2020 - Feb 15, 2024
Description:
yield, climate-resilient pea cultivars with enhanced seed quality.
Organization:
National Research Council Canada
Expected Results:

In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.

Location:
Ottawa, Ontario, CA K1N 6N5
Reference Number:
172-2020-2021-Q2-955911
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
119278877
Recipient Type:
Academia
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreement has been modified by 290 days.

Amendment Date
May 1, 2023
Recipient's Legal Name:
University of Ottawa
Federal Riding Name:
Ottawa--Vanier--Gloucester
Federal Riding Number:
35081
Program:
Collaborative Science, Technology and Innovation Program – Ideation Fund
Program Purpose:

The Ideation Fund is intended to encourage, test and validate transformative research ideas generated by teams of NRC scientific personnel and external collaborators with complementary capabilities, acting as a demonstration phase for a continually-evolving suite of research and development (R&D) deliverables at the NRC. The fund supports exploratory research through two mechanisms: the New Beginnings Initiative and the Small Teams Initiative.

NAICS Code:
541710
Amendments: